consumer genomics
23andMe CEO Wojcicki Not Open to Third-Party Takeover Proposals
In a regulatory filing, 23andMe CEO Anne Wojcicki issued a brief statement reiterating that she sees taking the company private as the "best path."
23andMe Receives Warning of Nasdaq Listing Noncompliance
The resignation of the company's independent directors triggered the warning, which grants the company until Oct. 3 to submit a plan to regain compliance.
23andMe Independent Board Directors Resign, Citing Lack of Progress on Take-Private Proposal
The directors wrote that disagreements on strategic direction and Wojcicki's sizable voting power meant that their resignation best served shareholder interests.
23andMe to Pay $30M in Data Breach Lawsuit Settlement
The company will also provide affected customers with three years of access to a security monitoring program.
DescendantsDNA Signs on Broad Clinical Labs as Sequencing Services Partner
DescendantsDNA provides its members DNA self-test kits and healthcare reports, generated using Fabric Genomics software, based on their genetic profiles.